Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on October 23, 2025
Xtract One Announces Fiscal 2025 Fourth Quarter and Full Year Results
TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) (“Xtract One” or the “Company”) a leading technology-driven threat detection and security solution that prioritizes the patron access experience …
Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
TORONTO and HOUSTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune …
Inventronics Announces 2025 Q3 Financial Results
CALGARY, Alberta, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Inventronics Limited (the “Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in Canada and …
Sabio Announces LIFE Offering of Up to $4 Million
Not for distribution to the United States wire services or dissemination in or into the United States. TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF) (the “Company” or “Sabio”), a Los Angeles-based ad-tech company …
Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
DEER PARK, Ill., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will …
La división Zena AI de ZenaTech, para soluciones avanzadas de drones impulsados por inteligencia artificial para defensa y seguridad nacional de EE. UU., tendrá su sede en Baton Rouge, Luisiana
VANCOUVER, Columbia Británica, Oct. 23, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), un proveedor de soluciones tecnológicas empresariales especializado en drones con inteligencia artificial (IA), Drone como …
BlackLine Announces Date for Third Quarter 2025 Earnings Release and Conference Call
LOS ANGELES, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL) announced today that it will release financial results for the third quarter ended September 30, 2025 after market close on Thursday, November 6, 2025 followed by a conference call …
Turtle Beach Corporation to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Turtle Beach Corporation (Nasdaq: TBCH) a leading gaming accessories brand, today announced it will report financial results for the third quarter 2025 on Thursday, November 6, 2025, after the close of trading …
IBEX Limited to Announce First Quarter 2026 Financial Results on November 6, 2025
WASHINGTON, Oct. 23, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”) (Nasdaq: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced it will report first quarter 2026 …
Teads to Release Third Quarter 2025 Financial Results on November 6, 2025
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Teads Holding Co. (NASDAQ: TEAD), announced today that the company will release its third quarter 2025 results before the market opens on Thursday, November 6, 2025, followed by a conference call at 8:30 a.m. ( …
Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its third …
First U.S. Dollars issued on-chain specially designed for retail customers worldwide
Pioneering consortium between Vast Bank, USBC Inc., and Uphold Uphold customers worldwide are expected to open U.S. dollar deposit accounts at Vast Bank, a nationally-chartered U.S. bank U.S. dollar-denominated tokenized deposits issued by Vast Bank USBC …
Definitive Healthcare Announces Timing of Its Third Quarter 2025 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its third quarter …
Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
New York, NY, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics Inc. (NASDAQ: QLGN) (“Qualigen”, “QLGN” or “Company”), a publicly-trading technology company majority owned by Faraday Future, today announced a strategic partnership with BitGo, the …
Iovance Biotherapeutics to Host Third Quarter 2025 Financial Results and Corporate Updates Webcast on Thursday, November 6, 2025
SAN CARLOS, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …
BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Data demonstrate potent suppression of MAPK signaling and viability in KRAS mutant cell lines, as well as anti-tumor activity across multiple KRASG12D and KRASG12V cell-derived xenograft (CDX) models BBO-11818’s selectivity for KRAS demonstrated by its > …
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors
SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the …
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …